INTELLIPHARMACEUTICS INTERNATIONAL INC. Operating Cash Flow
INTELLIPHARMACEUTICS INTERNATIONAL INC. reported Operating Cash Flow of $240.83 thousand for the 3-month period ending 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2024-02-06
- INTELLIPHARMACEUTICS INTERNATIONAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-08-31 was $240.83K.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-05-31 was $89.73K.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. net cash provided by (used in) operating activities for the quarter ending 2023-02-28 was -$14.18K.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. net cash provided by (used in) operating activities for the quarter ending 2022-11-30 was -$195.93K.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 11 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|
| 2023-08-31 | $240.83K 6-K · filed 2023-10-16 | $330.56K derived: sum of 2 quarters · filed 2023-10-16 | $316.38K 6-K · filed 2023-10-16 | $120.45K derived: sum of 4 quarters · filed 2024-02-06 | |
| 2023-05-31 | $89.73K 6-K · filed 2023-09-26 | $75.55K 6-K · filed 2023-09-26 | -$120.38K derived: sum of 3 quarters · filed 2024-02-06 | -$413.52K derived: sum of 4 quarters · filed 2024-02-06 | |
| 2023-02-28 | -$14.18K 6-K · filed 2023-09-26 | -$210.10K derived: sum of 2 quarters · filed 2024-02-06 | -$503.25K derived: sum of 3 quarters · filed 2024-02-06 | -$841.82K derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-11-30 | -$195.93K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | -$489.07K derived: sum of 2 quarters · filed 2024-02-06 | -$827.64K derived: sum of 3 quarters · filed 2024-02-06 | -$1.39M 20-F/A · filed 2024-02-06 | |
| 2022-08-31 | -$293.15K 6-K · filed 2023-10-16 | -$631.72K derived: sum of 2 quarters · filed 2023-10-16 | -$1.19M 6-K · filed 2023-10-16 | -$1.53M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-05-31 | -$338.57K 6-K · filed 2023-09-26 | -$899.15K 6-K · filed 2023-09-26 | -$1.23M derived: sum of 3 quarters · filed 2024-02-06 | -$2.60M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-02-28 | -$560.58K 6-K · filed 2023-09-26 | -$896.33K derived: sum of 2 quarters · filed 2024-02-06 | -$2.26M derived: sum of 3 quarters · filed 2024-02-06 | -$3.02M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2021-11-30 | -$335.75K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | -$1.70M derived: sum of 2 quarters · filed 2024-02-06 | -$2.46M derived: sum of 3 quarters · filed 2024-02-06 | -$2.46M 20-F/A · filed 2024-02-06 | |
| 2021-08-31 | -$1.36M 6-K · filed 2022-10-14 | -$2.13M derived: sum of 2 quarters · filed 2022-10-14 | -$2.13M 6-K · filed 2022-10-14 | ||
| 2021-05-31 | -$763.77K 6-K · filed 2022-07-21 | -$763.14K 6-K · filed 2022-07-21 | |||
| 2021-02-28 | $623.00 6-K · filed 2022-04-14 | ||||
| 2020-11-30 | $112.11K 20-F/A · filed 2024-02-06 | ||||
| 2020-02-29 | -$58.57K 6-K · filed 2021-04-14 | ||||
| 2019-11-30 | -$6.66M 20-F/A · filed 2022-05-09 | ||||
| 2013-11-30 | -$6.93M 20-F · filed 2014-02-18 | ||||
| 2012-11-30 | -$7.65M 20-F · filed 2014-02-18 | ||||
| 2011-11-30 | -$6.98M 20-F · filed 2014-02-18 | ||||
| 2010-11-30 | -$6.19M 20-F/A · filed 2013-02-01 | ||||
| 2009-11-30 | -$4.86M 20-F · filed 2012-05-11 |